Table 1.

Demographic and clinical characteristics of study participants categorized by CK levels

	Overall (n = 76)	Low CK (n = 32)	High CK (n = 44)	p-value
Age (years) mean ± SD	39.7 ± 9.7	41.5 ± 9.5	38 ± 8.8	0.83
Gender				0.024
Male	36 (47.3%)	20 (55.6%)	16 (44.4%)
Female	40 (52.7%)	12 (30%)	28 (70%)
Hypertension	7 (9.2%)	2 (28.6%)	5 (71.4%)	0.45
Diabetes	5 (6.6%)	1 (20%)	4 (80%)	0.37
Response				0.51
Good response	46 (60.5%)	18 (39%)	28 (71%)
Bad response	30 (39.5%)	14 (46.7%)	16 (53.3%)
Hg (g/dl) mean ± SD	11.6 ± 2	11.5 ± 2	11.8 ± 2	0.52
WBC (/mm 3) median (range)	6 (2.5–185)	6.3 (2.9–185)	5.5 (2.5–7.8)	0.06
Platelet (/mm 3) median (range)	197.5 (14–934)	214 (14–554)	176 (40–934)	0.2
AST (IU) median (range)	22 (12.2–115.4)	2.51 (14–115.4)	22 (12.2–44)	0.6
ALT (IU) median (range)	17.6 (7.4–117)	18 (8.7–117)	18 (7.4–72.3)	0.6
Creatinine (mg/dl) mean ± SD	0.88 ± 0.19	0.9 ± 0.2	0.89 ± 0.16	0.2
Urea (mg/dl) mean ± SD	24.3 ± 6.7	26.3 ± 7.6	22 ± 6.2	0.7
CK-MB	4.4 (0.4–28.68)	4.6 (0.4–26.83)	3.8 (0.41–28.68)	0.5

Data bold indicate p value is significant